Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Ascentage Pharma Group International - Unsponsored ADR (AAPG) had Return on Equity of -147.97% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$134.35M |
|
$-55.54M |
|
$3.98M |
|
$130.36M |
|
$179.63M |
|
$-45.28M |
|
$-8.87M |
|
$-54.15M |
|
$-54.15M |
|
$-55.58M |
|
$-55.58M |
|
$-55.58M |
|
$-55.58M |
|
$-45.28M |
|
$-34.04M |
|
75.52M |
|
75.52M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$201.96M |
|
$116.37M |
|
$156.68M |
|
$358.64M |
|
$159.82M |
|
$121.85M |
|
$161.25M |
|
$321.08M |
|
$37.56M |
|
$23.77M |
|
$37.56M |
|
78.81M |
|
| Cash Flow Statement Financials | |
$-15.26M |
|
$-49.60M |
|
$43.12M |
|
$142.21M |
|
$122.35M |
|
$-19.86M |
|
$2.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
0.76 |
|
6.09 |
|
97.03% |
|
-33.70% |
|
-33.70% |
|
-25.34% |
|
-40.30% |
|
-41.34% |
|
$-18.58M |
|
-- |
|
-- |
|
-- |
|
0.37 |
|
4.41 |
|
11.80 |
|
30.94 |
|
|
Return on Equity |
-147.97% |
-233.86% |
|
-15.50% |
|
-34.86% |
|
$0.48 |
|
$-0.25 |
|
$-0.20 |
|